For instance, recent research has elaborated that the silence of PKM2 increases the sensitivity of bladder cancer to pirarubicin (THP) in vivo and in vitro by activating AMPK and inhibiting STAT3.21 Here, PKM is linked to urinary bladder carcinoma.